83 related articles for article (PubMed ID: 8460337)
1. Interferon alpha-2b treatment in an HIV-infected patient with hepatitis B virus induced nephrotic syndrome.
Lidman C; Magnius L; Norder H; Weiland O
Scand J Infect Dis; 1993; 25(1):133-5. PubMed ID: 8460337
[TBL] [Abstract][Full Text] [Related]
2. Interferon treatment of hepatitis B-associated membranous glomerulonephritis and nephrotic syndrome.
Giboa N; Neigut D
Pediatr Nephrol; 1993 Jun; 7(3):328-9. PubMed ID: 8518110
[No Abstract] [Full Text] [Related]
3. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha interferon.
Abbas NA; Pitt MA; Green AT; Solomon LR
Nephrol Dial Transplant; 1999 May; 14(5):1272-5. PubMed ID: 10344378
[No Abstract] [Full Text] [Related]
5. Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection.
Endo M; Ohi H; Fujita T; Ohsawa I; Kanmatsuse K; Yamaguchi Y
Am J Nephrol; 1998; 18(5):439-43. PubMed ID: 9730572
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
[TBL] [Abstract][Full Text] [Related]
7. Membranous nephropathy related to hepatitis B virus in adults.
Lai KN; Li PK; Lui SF; Au TC; Tam JS; Tong KL; Lai FM
N Engl J Med; 1991 May; 324(21):1457-63. PubMed ID: 2023605
[TBL] [Abstract][Full Text] [Related]
8. Remission of nephrotic syndrome of HBV-associated membranous glomerulopathy following treatment with interferon.
Shapiro RJ; Steinbrecher UP; Magil A
Am J Nephrol; 1995; 15(4):343-7. PubMed ID: 7573195
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
10. [Secondary nephrotic syndrome induced by infection].
Kawasaki Y
Nihon Rinsho; 2004 Oct; 62(10):1925-9. PubMed ID: 15500141
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha 2b treatment in hepatitis B carriers. Effect on hepatitis B virus DNA levels in children infected with different genotypes.
Sangfelt P; Norder H; Magnius LO; Alaeus A; Carlsson T; Reichard O
Acta Paediatr; 1997 Feb; 86(2):135-7. PubMed ID: 9055880
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
[TBL] [Abstract][Full Text] [Related]
14. The clinical course of hepatitis B virus-associated nephropathy.
Gilbert RD; Wiggelinkhuizen J
Pediatr Nephrol; 1994 Feb; 8(1):11-4. PubMed ID: 8142208
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
16. alpha-Interferon therapy for HBV-related glomerulonephritis.
Lopes Neto EP; Lopes LV; Kirsztajn GM; Cruz CN; Ferraz ML; Silva AE
Sao Paulo Med J; 1998; 116(5):1823-5. PubMed ID: 10030109
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
[TBL] [Abstract][Full Text] [Related]
19. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
[TBL] [Abstract][Full Text] [Related]
20. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
